Home | Business News | Browse by Publication | B | Biotech Business

ANGIOGENEX REVIEWS 2008 AND SETS GOALS FOR 2009.

Publication: Biotech Business
Publication Date: 01-JAN-09
Format: Online
Delivery: Immediate Online Access

Article Excerpt
AngioGenex, Inc. (OTC Bulletin Board: AGGX) is a New York- based biotechnology company that leads in targeting Id genes and proteins for the discovery and development of anti- angiogenic drugs to treat cancer. Now, the company has announced achievement of its 2008 objectives and its key business goals for 2009.

AngioGenex accomplished a number of important milestones that it set for itself in 2008. In the Research and Development area, the company completed key pilot studies on novel anti-angiogenic drugs and filed US and foreign patent applications for...

Access Full Article, Compliments of Goliath

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Biotech Business
SIGMA-ALDRICH/D-FINITIVE CELL TO DEVELOP REGENERATIVE TOOLS., January 01, 2009
FDA APPROVES PLC SYSTEMS PIVOTAL TRIAL OF RENALGUARD IN U.S., January 01, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.